<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Experimental Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5091098B-EBC1-4912-B990-A701492C662E"><gtr:id>5091098B-EBC1-4912-B990-A701492C662E</gtr:id><gtr:firstName>Branch</gtr:firstName><gtr:surname>Moody</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7595802E-E92D-4C6E-9758-7C0AC73A3C69"><gtr:id>7595802E-E92D-4C6E-9758-7C0AC73A3C69</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Simmons</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/42EE47A1-8247-4CCB-B7D5-99FD2758D80B"><gtr:id>42EE47A1-8247-4CCB-B7D5-99FD2758D80B</gtr:id><gtr:firstName>Vincenzo</gtr:firstName><gtr:surname>Cerundolo</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AF06FFB1-235A-4F06-81B7-A0E1F5879D2C"><gtr:id>AF06FFB1-235A-4F06-81B7-A0E1F5879D2C</gtr:id><gtr:firstName>Giorgio</gtr:firstName><gtr:surname>Napolitani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1FD0D626-4BED-4511-8F19-E9D823D31663"><gtr:id>1FD0D626-4BED-4511-8F19-E9D823D31663</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Pollard</gtr:surname><gtr:orcidId>0000-0001-7361-719X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6804423C-C1B3-4965-8F61-7FFC983481EC"><gtr:id>6804423C-C1B3-4965-8F61-7FFC983481EC</gtr:id><gtr:firstName>Melita</gtr:firstName><gtr:otherNames>Alison</gtr:otherNames><gtr:surname>Gordon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK021222%2F1"><gtr:id>CA045360-2456-445D-9580-B7C1C0C5DD11</gtr:id><gtr:title>MICA: Study of disease mechanisms in enteric fever to characterise innate &amp;amp; adaptive immunity in mucosa &amp;amp; blood in controlled human infection model</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K021222/1</gtr:grantReference><gtr:abstractText>Typhoid fever (also known as enteric fever), an infection characterised by diarrhoea and rash, is most often caused by a type of bacteria called Salmonella enterica. After gaining entry to the body via contaminated food or drink, the Salmonellae travel first to the gut, and then the bloodstream, from where they can infect the lymph nodes, gallbladder, liver, spleen, and other parts of the body. Treatment of enteric fever is by rehydration either intravenously or by drinking uncontaminated water mixed with electrolytes. Antibiotics are used to kill the bacteria, but as there are increasing rates of antibiotic resistant S. enterica throughout the world, this means of treatment is becoming less effective. 

Two Salmonella variants, known as serovars Typhi and Paratyphi, cause around 27 million cases of enteric fever and more than 200,000 deaths per year worldwide, mostly in the developing countries. Even though improved sanitation through economic development should eventually eliminate enteric fever, reduction of the disease burden in the medium term is achievable through effective immunisation, especially in the face of increasing antibiotic resistance.

Although effective vaccines are likely to be available for mass vaccination against typhoid in the near future, these vaccines will be effective only against those strains of S. Typhi and S. Paratyphi that bear the Vi polysaccaharide capsule proteins. Strains that do not have these capsule proteins, or that have no capsule (acapsulate) will be unaffected by vaccination and could fill the ecological space vacated by the capsulate strains. Indeed, enteric fever caused by S. Paratyphi A which does not carry the Vi protein and for which there is currently no vaccine, has risen during the past decade and accounts for more than half of all cases in some areas. 

Thus it is important that effective vaccines are available to protect against infection by both capsulated and non-encapsulated Salmonella enterica. To develop such vaccines, we need a full understanding of the human immune response to the acapsulate Salmonella including the interactions between the inbuilt immune system and disease-specific immunity, contributions of immunity in the gut and the bloodstream, immune response to protein and to polysaccharide determinants, and the role of antibodies. How much cross-protection there is between capsulate and non-capsulate typhoidal Salmonellae after natural infection or vaccination is not known, but this is critically important to vaccine development.

With this project we aim to fill in the knowledge gaps highlighted above, by fully characterising the infection process and immune response in enteric fever.</gtr:abstractText><gtr:technicalSummary>Vaccines for S. enterica currently under development are based on the S. Typhi and S. Paratyphi C Vi polysaccaharide capsule. However, enteric fever caused by S. Paratyphi A (which does not carry Vi) and for which there is currently no vaccine, has risen in the past decade and accounts for more than 50% of cases in some areas.
Design and evaluation of effective vaccines is limited by a gap in understanding the mechanisms of susceptibility to capsulate and non-capsulate typhoidal Salmonellae.
To fill this knowledge gap we will extend a controlled human infection model (developed by us in Oxford) with S. Typhi to infection with S. Paratyphi by challenging volunteers previously exposed to S. Typhi with either S. Typhi or S. Paratyphi. We will be able to relate responses in a controlled human infection model to natural protection, and use this for potential vaccine antigen discovery.

We aim to: A) identify the systemic and mucosal location of bacteria to determine potential for humoral and cellular protection; B) compare innate responses to S. Typhi and Paratyphi in peripheral blood and mucosa in individuals resistant and susceptible to infection; C) define the phenotype and antigen specificities of B cell and T cells responses against the two pathogens to identify correlates of protection against reinfection; D) identify CD1 restricted Salmonella derived lipid antigens that are conserved between different Salmonella strains and which may be used as T cell antigens for alternative vaccination strategies.

Our findings will be further validated in naturally exposed individuals in the Mucosal Research Unit within the Wellcome Trust Major Overseas Unit in Malawi.
This programme will give new insights into the innate and adaptive immune responses and the pathogenesis of human infection with the bacteria that cause enteric fever. It will provide important correlates of protection that will facilitate the design and optimisation of novel vaccination strategies.</gtr:technicalSummary><gtr:potentialImpactText>There are a large number of potential beneficaries of the proposed research since this is a wide-ranging multi-disciplinary pogramme including but not limited to:

1) Researchers in the field of enteric pathogens could use the approach we are planning to guide new investigation with enteric pathogens or replicate our model
2) Immunology researchers will gain new insight into the interaction between innate and acquired immune responses and bacteria which can be used to investigate other organisms 
3) Vaccine developers in the commercial private sector who could use the data to guide development of improved vaccines or test their new products in the challenge model
4) The information produced in this project will be of interest to agencies that are currently considering implementation of vaccines for enteric fever including the World Health Organisation, Global Alliance for vaccines and immunisation (GAVI) and the Bill and Melinda Gates Foundation.
5) The project may also provide new insight into correlates of protection which would be of special interest to regulators
6) The project will generate considerable public interest and includes some important and compelling themes which can be readily conveyed to the public to enhance the understanding of science.
7) If the research were to support or lead to new or improved vaccines for enteric fever, there would be a major impact on the large numbers of individuals who are exposed to these pathogens and are at risk. 
8) Reducing the burden of this disease has the potential to directly impact on the physical and economic health of affected populations.
9) The project provides a remarkable training opportunity for clinical trainees engaged in the trial and the endoscopy to learn about clinical research and for them to be introduced to the laboratory research that the clinical plan supports.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3666736</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Collaboration with Harvard University</gtr:description><gtr:id>C7917DAF-2409-443E-8C17-15D497418A86</gtr:id><gtr:impact>Publications of papers in peer-reviewed journals.</gtr:impact><gtr:outcomeId>58c91545bcc387.57324272-1</gtr:outcomeId><gtr:partnerContribution>Collaborative project</gtr:partnerContribution><gtr:piContribution>Analysis of CD1 restricted Salmonella-specific T cell responses</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Professor Sarah Teichmann</gtr:description><gtr:id>2B82C46A-395A-4E3C-9DC9-857F6D142E76</gtr:id><gtr:impact>No published outcome yet</gtr:impact><gtr:outcomeId>58c7f22871c1e4.42495727-1</gtr:outcomeId><gtr:partnerContribution>Collaborative project</gtr:partnerContribution><gtr:piContribution>Single cell RNAseq analysis of CD4 T cell responses to Salmonella Typhi and Paratyphi</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Professor Gordon Dougan</gtr:description><gtr:id>4560DF75-D092-46B7-8BC3-2F2F035582A1</gtr:id><gtr:impact>No published outcome yet</gtr:impact><gtr:outcomeId>58c7f275ab88a5.01157751-1</gtr:outcomeId><gtr:partnerContribution>Collaborative project</gtr:partnerContribution><gtr:piContribution>Use of libraries of Salmonella specific T cell clones generated from Salmonella infected volunteers to identify and characterize cross-reactive and serovar specific Salmonella T cell antigens</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Basel</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Biozentrum Basel</gtr:department><gtr:description>Collaboration with Professor Dirk Bumann</gtr:description><gtr:id>6B560A15-8B37-4021-9DD0-72B0C6A1FA14</gtr:id><gtr:impact>No published outcome yet</gtr:impact><gtr:outcomeId>58c7f37c01e501.09201982-1</gtr:outcomeId><gtr:partnerContribution>Collaborative project</gtr:partnerContribution><gtr:piContribution>Use of libraries of Salmonella specific T cell clones generated from Salmonella infected volunteers to identify and characterize cross-reactive and serovar specific Salmonella T cell antigens</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Collaboration with Professor Dick Strugnell</gtr:description><gtr:id>ADA98D25-4EAE-4C0F-8360-5C29273FEF9A</gtr:id><gtr:impact>No published outcome yet</gtr:impact><gtr:outcomeId>58c7f3d3cdcf83.85847357-1</gtr:outcomeId><gtr:partnerContribution>Collaborative project</gtr:partnerContribution><gtr:piContribution>Use of libraries of Salmonella specific T cell clones generated from Salmonella infected volunteers to identify and characterize cross-reactive and serovar specific Salmonella T cell antigens</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Vaccine Group</gtr:department><gtr:description>Collaboration with the Oxford Vaccine Group</gtr:description><gtr:id>679E637E-878F-4140-A5FA-3F075C45309F</gtr:id><gtr:impact>Collaboration still ongoing</gtr:impact><gtr:outcomeId>56deab019ea719.34225520-1</gtr:outcomeId><gtr:partnerContribution>As a joint collaboration, we are investigating disease mechanisms in enteric fever to characterise innate and adaptive immunity in mucosa and blood in controlled human infection models</gtr:partnerContribution><gtr:piContribution>In the context of the MRC Experimental Medicine Challenge Grant, my group has set up a close collaboration with the Oxford Vaccine Group directed by Professor Andrew Pollard.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oxfordshire Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7F12387D-98DE-4D0A-BEAB-61611A9115E9</gtr:id><gtr:impact>To showcase our multi-disciplinary department through interactive demonstrations and hands-on activities.</gtr:impact><gtr:outcomeId>58b6a7b3c99473.12646672</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Festival of Medical Research</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3C85BFF4-6BC5-477C-A72F-E066391C942B</gtr:id><gtr:impact>To showcase and discuss the important work carried out in the Unit</gtr:impact><gtr:outcomeId>58b6a841510588.05134194</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Publication of glossy brochure for dissemination</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>62EE794B-AAA8-460D-A09D-B0249C07DC2B</gtr:id><gtr:impact>Development and publication of a glossy brochure illustrating in lay terms the important work carried out in the unit and dissemination to the general public.</gtr:impact><gtr:outcomeId>58b6adbb37e217.62815398</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science evening at Eynsham Primary School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2243F946-0FA4-489F-816A-81C2BA55998A</gtr:id><gtr:impact>A hands-on interactive science evening at a local primary school</gtr:impact><gtr:outcomeId>58b6a962c55ae3.56659664</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience visits by 5th &amp; 6th year students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2BB3FC34-B116-44E6-979C-6C1BEADC8D1D</gtr:id><gtr:impact>Work experience visits to the MRC Human Immunology Unit by a total of 19 students in 2016.</gtr:impact><gtr:outcomeId>58b6aa041d0918.83906435</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit by 50 students from the Utrecht Junior School, the Netherlands</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AC05084D-5A8D-47E5-8AAC-887B2B18CBC3</gtr:id><gtr:impact>A group of 50 students from Utrecht Junior College in the Netherlands took place in the WIMM and the MRC Human Immunology Unit. 100% of students who attended said that they both enjoyed the day and learnt something new about science.</gtr:impact><gtr:outcomeId>56dd826d6bbda8.15372859</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work Experience students in the MRC Human Immunology Unit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>05BC7024-F5FD-4552-8BB2-9EF859A23251</gtr:id><gtr:impact>The PIs in the MRC Human Immunology Unit hosted a total of 11 young students (16 and 17 year olds) on a work experience placement of one or two weeks, with the aim of fostering an interest in a scientific career and raising awareness in the type of work carried out in the Unit</gtr:impact><gtr:outcomeId>56dd8013c8e516.04052173</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>762A6200-A80D-495C-9AD0-1F6EB7E24831</gtr:id><gtr:title>MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi&amp;nbsp;A.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f08f07df060c5266f71cbf63bc9e76"><gtr:id>67f08f07df060c5266f71cbf63bc9e76</gtr:id><gtr:otherNames>Howson LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a9e77ce81c8d4.97401187</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K021222/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>